Thomas Winkler, MD
Otolaryngology · Chevy Chase, MDNPI 1023163706
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,165 of the $2,955 with a category attached, or 73.3%. Aerin Medical Inc. accounts for 78.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $1,871 and has fallen 68.9% since, to $582 in 2025.
Across 35 payments — averaging $84.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$2K
- Medtronic$161
- Acclarent, Inc$153
- Corcept Therapeutics$129
- Phathom Pharmaceuticals, Inc.$115
- Stryker$28
- plus $37 from 2 others
What the payments were for
- Travel & lodging$76126%
- Food & beverage$2,16573%
- Education$281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 27 | $2,332 |
| Medtronic | 1 | $161 |
| Acclarent, Inc | 2 | $153 |
| Corcept Therapeutics | 1 | $129 |
| Phathom Pharmaceuticals, Inc. | 1 | $115 |
| Stryker | 1 | $28 |
| BD | 1 | $21 |
| Optinose US, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$1,577
- RHINAER STYLUS$456
- RELIEVA SPINPLUS Balloon Sinuplasty System$244
- FUSION$161
- Korlym$129
- VOQUEZNA$115
- Vivaer RF Stylus$110
How this compares
$2,955 in reported general payments places this provider in the 75th percentile of 222 otolaryngology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 74 | $1,955 |
| Mometasone Furoate | 28 | $1,812 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 12 | $1,280 |
| Fluticasone Propionate | 39 | $843 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 15 | $653 |
| CefuroximeCefuroxime Axetil | 24 | $479 |
| Ofloxacin | 11 | $406 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $253 |
| Prednisone | 35 | $195 |
| Azithromycin | 12 | $99 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Chevy Chase
- Seth OringherChevy Chase$429K
- Natalie EarlChevy Chase$14K
- Philip SchoenfeldChevy Chase$5K
- Jack WilliamsChevy Chase$4K
- Jessica ShenChevy Chase$4K
- Marc DubinBaltimore$350K
- Douglas RehLutherville Timonium$231K
- Patrick HaBaltimore$41K
- Joshua LevyBethesda$40K
- Andrew LaneBaltimore$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.